Total Tumor Volume Predicts Overall Survival and Response to Induction Chemotherapy in Patients with Colorectal Cancer Liver Metastases: An Ancillary Study of the Phase 3 Cairo5 Trial
Ruby Kemna(Vrije Universiteit Amsterdam), Geert Kazemier(European Organisation for Research and Treatment of Cancer), Inez M. Verpalen(Amsterdam Neuroscience), John J. Hermans(Erasmus MC), Janneke E. van den Bergh(Dutch Cancer Society), Nina J. Wesdorp(Vrije Universiteit Amsterdam), Krijn van Lienden, Rutger‐Jan Swijnenburg(Amsterdam University Medical Centers), Jaap Stoker(University of Amsterdam), Martin van Amerongen(Sint Maartenskliniek), Mike S.L. Liem(Medisch Spectrum Twente), Susan van Dieren(Amphia Ziekenhuis), Shira Moos(Amsterdam Neuroscience), Mahsoem Ali(Amsterdam Neuroscience), Theo J. M. Ruers(The Netherlands Cancer Institute), Michiel Zeeuw(Amsterdam University Medical Centers), Ronald M. van Dam(Maastricht University Medical Centre), Gijs A. Patijn(Isala), I. Quintus Molenaar(Utrecht University), Cornelis J.A. Punt(Utrecht University), Wouter K.G. Leclerq(Radboud University Nijmegen), Tineke E. Buffart(Amsterdam University Medical Centers), Michael F. Gerhards(Erasmus MC), Joost Huiskens(Amsterdam UMC Location University of Amsterdam), Joost M. Klaase(University Medical Center Groningen), Dirk J. Grünhagen(Erasmus MC), Arjen M. Rijken(Amphia Ziekenhuis), Joran Roor, Hans W. de Wilt(Radboud University Nijmegen), Koert de Jong(University Medical Center Groningen), Irene M G C Nota(Amsterdam Neuroscience), Marc Engelbrecht(University of Amsterdam), Thomas M. van Gulik(Amsterdam University Medical Centers), J.H.T.M. van Waesberghe(Amsterdam UMC Location Vrije Universiteit Amsterdam), Marinde J. G. Bond(Utrecht University), Niels F.M. Kok(The Netherlands Cancer Institute), Cornelis Verhoef(Erasmus MC Cancer Institute)
Cited by 0
Related Papers
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
|Journal of Crohn s and Colitis|2018|1.8k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Direct detection of early-stage cancers using circulating tumor DNA
|Science Translational Medicine|2017|1.1k